OP0102 Patient reported benefits of sarilumab monotherapy versus adalimumab monotherapy in adult patients with active rheumatoid arthritis

V Strand; L Gossec; C Proudfoot; C Chen; M Reaney; S Guillonneau; T Kimura; J van Adelsberg; Y Lin; E Mangan; H van Hoogstraten; GR Burmester

doi:10.1136/annrheumdis-2017-eular.2955

Article info

Oral Presentations

Progress in biological treatment of RA

OP0102 Patient reported benefits of sarilumab monotherapy versus adalimumab monotherapy in adult patients with active rheumatoid arthritis

Free

Authors

V Strand 1Stanford University, Palo Alto, United States PubMed articles Google scholar articles
L Gossec 2Universite Pierre et Marie Curie and Hopital Pitie-Salpetriere, Paris, France PubMed articles Google scholar articles
C Proudfoot 3Sanofi, Guildford, United Kingdom PubMed articles Google scholar articles
C Chen 4Regeneron Pharmaceuticals, Inc., Tarrytown, United States PubMed articles Google scholar articles
M Reaney 3Sanofi, Guildford, United Kingdom PubMed articles Google scholar articles
S Guillonneau 5Sanofi, Paris, France PubMed articles Google scholar articles
T Kimura 4Regeneron Pharmaceuticals, Inc., Tarrytown, United States PubMed articles Google scholar articles
J van Adelsberg 4Regeneron Pharmaceuticals, Inc., Tarrytown, United States PubMed articles Google scholar articles
Y Lin 6Sanofi, Bridgewater, United States PubMed articles Google scholar articles
E Mangan 4Regeneron Pharmaceuticals, Inc., Tarrytown, United States PubMed articles Google scholar articles
H van Hoogstraten 6Sanofi, Bridgewater, United States PubMed articles Google scholar articles
GR Burmester 7Charité - University Medicine, Berlin, Germany PubMed articles Google scholar articles

Citation

Strand V, Gossec L, Proudfoot C, et al

OP0102 Patient reported benefits of sarilumab monotherapy versus adalimumab monotherapy in adult patients with active rheumatoid arthritis

Annals of the Rheumatic Diseases 2017;76:94.

Publication history

First published June 15, 2017.

Online issue publication

January 09, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password